Cargando...
Response of Degarelix treatment in human prostate cancer monitored by HR-MAS (1)H NMR spectroscopy
INTRODUCTION: The androgen receptor (AR) is the master regulator of prostate cancer cell metabolism. Degarelix is a novel gonadotrophin-releasing hormone blocker, used to decrease serum androgen levels in order to treat advanced human prostate cancer. Little is known of the rapid metabolic response...
Guardado en:
| Publicado en: | Metabolomics |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer US
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4927592/ https://ncbi.nlm.nih.gov/pubmed/27429605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-016-1055-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|